SBI Pharma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • 2ndary - Private

SBI Pharma General Information

Description

Developer of a biotechnology platform designed to commercialize 5-aminolevulinic acid for applications in health and medicine. The company offers proprietary 5-ALA manufacturing methods and a range of products in healthcare, cosmetics, and diagnostics, enabling individuals, patients, and aging populations to support metabolic function, improve health, and aid in disease detection.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Izumi Garden Tower 20th Floor, 1-6-1
  • Roppongi, Minato-ku, Direct link with Roppongi 1-chome Station
  • Tokyo, 106-6020
  • Japan
+81
Primary Industry
Pharmaceuticals
Corporate Office
  • Izumi Garden Tower 20th Floor, 1-6-1
  • Roppongi, Minato-ku, Direct link with Roppongi 1-chome Station
  • Tokyo, 106-6020
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SBI Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Dec-2022 Completed Generating Revenue
1. Seed Round Completed Generating Revenue
To view SBI Pharma’s complete valuation and funding history, request access »

SBI Pharma Patents

SBI Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023228176-A1 Pharmaceutical composition for preventing and/or treating autoimmune diseases Pending 01-Mar-2022
EP-4487843-A1 Pharmaceutical composition for preventing and/or treating autoimmune diseases Pending 01-Mar-2022
EP-4487843-A4 Pharmaceutical composition for preventing and/or treating autoimmune diseases Pending 01-Mar-2022
JP-7628237-B2 Pharmaceutical composition for preventing and/or treating autoimmune diseases Active 01-Mar-2022
US-20250262179-A1 Pharmaceutical composition for preventing and/or treating autoimmune diseases Pending 01-Mar-2022 A61K31/197
To view SBI Pharma’s complete patent history, request access »

SBI Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SBI Pharma Investments (1)

SBI Pharma’s most recent deal was a Joint Venture with SBI Neopharma FZ. The deal was made on 01-Dec-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SBI Neopharma FZ 01-Dec-2016 Joint Venture Biotechnology
To view SBI Pharma’s complete investments history, request access »

SBI Pharma FAQs

  • When was SBI Pharma founded?

    SBI Pharma was founded in 2008.

  • Where is SBI Pharma headquartered?

    SBI Pharma is headquartered in Tokyo, Japan.

  • What is the size of SBI Pharma?

    SBI Pharma has 50 total employees.

  • What industry is SBI Pharma in?

    SBI Pharma’s primary industry is Pharmaceuticals.

  • Is SBI Pharma a private or public company?

    SBI Pharma is a Private company.

  • What is SBI Pharma’s current revenue?

    The current revenue for SBI Pharma is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process